BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Glaxosmithkline Pharmaceuticals Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
500660
ISIN Demat
INE159A01016
Book Value (Rs)
132.2958859
NSE Symbol
GLAXO
Divident Yield %
2.69
Market Cap
(Rs In Cr.)
35,926
P/E (TTM)
39.57
EPS (TTM)
53.59
Face Value
(Rs)
10
Back
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
13-May-26   Hrs IST

Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales995.30974.37 2 3821.673749.21 2
OPM %35.2634.20 -34.2631.40 -
PBDT386.27373.29 3 1451.831321.98 10
PBT373.10358.57 4 1385.391255.19 10
NP277.86262.87 6 1035.98927.58 12

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)